These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30777651)

  • 1. OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trial.
    Vizcarra JA; Lopez-Castellanos JR; Dwivedi AK; Schmerler DA; Ries S; Espay AJ
    Parkinsonism Relat Disord; 2019 Jun; 63():174-178. PubMed ID: 30777651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Botulinum Neurotoxin Injection for Dystonic Hand Tremor: A Randomized Clinical Trial.
    Rajan R; Srivastava AK; Anandapadmanabhan R; Saini A; Upadhyay A; Gupta A; Vishnu VY; Pandit AK; Vibha D; Singh MB; Bhatia R; Goyal V; Dwivedi SN; Srivastava P; Prasad K
    JAMA Neurol; 2021 Mar; 78(3):302-311. PubMed ID: 33346814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.
    Dadgardoust PD; Rosales RL; Asuncion RM; Dressler D
    J Neural Transm (Vienna); 2019 Feb; 126(2):141-148. PubMed ID: 30604200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
    Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
    Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early botulinum toxin treatment for spastic pes equinovarus--a randomized double-blind placebo-controlled study.
    Fietzek UM; Kossmehl P; Schelosky L; Ebersbach G; Wissel J
    Eur J Neurol; 2014 Aug; 21(8):1089-1095. PubMed ID: 24754350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up.
    Kruisdijk JJ; Koelman JH; Ongerboer de Visser BW; de Haan RJ; Speelman JD
    J Neurol Neurosurg Psychiatry; 2007 Mar; 78(3):264-70. PubMed ID: 17185301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OnabotulinumtoxinA treatment for MS-tremor modifies fMRI tremor response in central sensory-motor integration areas.
    Boonstra FMC; Evans A; Noffs G; Perera T; Jokubaitis V; Stankovich J; Vogel AP; Moffat BA; Butzkueven H; Kolbe SC; van der Walt A
    Mult Scler Relat Disord; 2020 May; 40():101984. PubMed ID: 32062446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial.
    Pinto RA; Costa D; Morgado A; Pereira P; Charrua A; Silva J; Cruz F
    J Urol; 2018 Apr; 199(4):998-1003. PubMed ID: 29031769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incobotulinum toxin A in Parkinson's disease with foot dystonia: A double blind randomized trial.
    Rieu I; Degos B; Castelnovo G; Vial C; Durand E; Pereira B; Simonetta-Moreau M; Sangla S; Fluchère F; Guehl D; Burbaud P; Geny C; Gayraud D; Ory-Magne F; Bouhour F; Llinares E; Derost P; Marques A; Durif F
    Parkinsonism Relat Disord; 2018 Jan; 46():9-15. PubMed ID: 29102441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haptic Feedback Manipulation During Botulinum Toxin Injection Therapy for Focal Hand Dystonia Patients: A Possible New Assistive Strategy.
    Atashzar SF; Shahbazi M; Ward C; Samotus O; Delrobaei M; Rahimi F; Lee J; Jackman M; Jog MS; Patel RV
    IEEE Trans Haptics; 2016; 9(4):523-535. PubMed ID: 27552765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OnabotulinumtoxinA for the Treatment of Poststroke Distal Lower Limb Spasticity: A Randomized Trial.
    Wein T; Esquenazi A; Jost WH; Ward AB; Pan G; Dimitrova R
    PM R; 2018 Jul; 10(7):693-703. PubMed ID: 29330071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS
    Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Mathew NT; Frishberg BM; Gawel M; Dimitrova R; Gibson J; Turkel C;
    Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of single-dose onabotulinumtoxinA in the treatment of symptoms of osteoarthritis of the knee: results of a placebo-controlled, double-blind study.
    McAlindon TE; Schmidt U; Bugarin D; Abrams S; Geib T; DeGryse RE; Kim K; Schnitzer TJ
    Osteoarthritis Cartilage; 2018 Oct; 26(10):1291-1299. PubMed ID: 29753118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia.
    Scorr LM; Silver MR; Hanfelt J; Sperin E; Freeman A; Jinnah HA; Factor SA
    Neurotherapeutics; 2018 Apr; 15(2):452-458. PubMed ID: 29542022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial.
    Attal N; de Andrade DC; Adam F; Ranoux D; Teixeira MJ; Galhardoni R; Raicher I; Üçeyler N; Sommer C; Bouhassira D
    Lancet Neurol; 2016 May; 15(6):555-65. PubMed ID: 26947719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral appliances in the treatment of oromandibular dystonia: a systematic review.
    De Meyer M; Vereecke L; Bottenberg P; Jacquet W; Sims AB; Santens P
    Acta Neurol Belg; 2020 Aug; 120(4):831-836. PubMed ID: 32594465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia.
    Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP
    Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.